Quest Diagnostics Incorporated – Consensus Indicates Potential 18.7% Upside
Quest Diagnostics Incorporated with ticker code (DGX) now have 14 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 185 and 129 and has a mean target at 151.86. Given that the stocks previous close was at 127.98 this is indicating there is a potential upside of 18.7%. The 50 day moving average now sits at 136.4 and the 200 day moving average is 144.03. The market cap for the company is $15,333m. Find out more information at: https:||www.questdiagnostics.com [stock_market_widget type="chart" template="basic" color="green" assets="DGX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $18,193m based on the market concensus. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Quest Diagnostics Incorporated – Consensus Indicates Potential 18.7% Upside
Quest Diagnostics Incorporated with ticker code (DGX) now have 14 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 185 and 129 and has a mean target at 151.86. Given that the stocks previous close was at 127.98 this is indicating there is a potential upside of 18.7%. The 50 day moving average now sits at 136.4 and the 200 day moving average is 144.03. The market cap for the company is $15,333m. Find out more information at: https:||www.questdiagnostics.com [stock_market_widget type="chart" template="basic" color="green" assets="DGX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $18,193m based on the market concensus. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.